Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

PRP shows promise but lacks consistent evidence and regulation.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Oral spironolactone may be effective for female pattern hair loss with a low rate of side effects.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Combining yoga and certain herbs can effectively manage PCOS symptoms and improve quality of life.

A young man's cheek papule was identified as a benign hair follicle tumor using a skin surface microscope.

Understanding how different body systems interact can improve how we prevent or treat frailty in aging.

PRP is promising for skin, hair, and wound treatments but needs standardized methods and more research.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Botulinum Toxin A may help with hair growth and has some side effects; more research is needed.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

High uric acid levels link to male pattern baldness, especially in young men.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Skin Radiance Collagen improved skin and hair health in adult females.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Using architecture as inspiration helps fashion design students become more creative and strengthens Saudi identity in fashion.

Increasing sleep by 41 minutes daily for a month showed no significant changes in metabolism or hormone levels in healthy women.